Evidence mapPaperPMID 40385776Full record

ReviewCureus2025

Determinants of Poor Glycemic Control Among Type 2 Diabetes Patients: A Systematic Review.

Yasir Ahmed, Fatema Kamaleldien Mohamed Abuelass, Salah Babiker Hamd Abdelwahab, Musab Mukhtar, Yousri Ahmed, Mohamed Elfahal, Nahid Siddig Mohmed Elhussein

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yasir AhmedAcute Medicine, University Hospital of North Midlands, Stoke-on-Trent, GBR.
Fatema Kamaleldien Mohamed AbuelassInternal Medicine, East Lancashire Teaching Hospital, Haslingden Road, Blackburn, GBR.
Salah Babiker Hamd AbdelwahabMedicine, Gloucester Royal Hospital, Gloucester, GBR.
Musab MukhtarGastroenterology, Sheikh Khalifa Specialty Hospital, Ras Alkhaimeh, ARE.
Yousri AhmedAccident and Emergency Department, Nizwa Hospital, Nizwa, OMN.
Mohamed ElfahalEmergency Medicine, Royal Oldham Hospital, Altringham, GBR.
Nahid Siddig Mohmed ElhusseinInternal Medicine, Dr. Soliman Fakeeh Hospital Home Health Care, Jeddah, SAU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Poor glycemic control remains a pervasive challenge in type 2 diabetes mellitus (T2DM) management, contributing to elevated risks of complications and healthcare burdens globally. This systematic review aimed to synthesize evidence on the determinants of poor glycemic control (hemoglobin A1C (HbA1c) >7%) among adults with T2DM. We followed PRISMA guidelines to search for relevant studies across five different databases, where we found 239 studies. First, the studies were screened for duplicates and then assessed for eligibility by screening through titles, abstracts, and ultimately full text. Upon carefully assessing for eligibility using inclusion and exclusion criteria, only 12 studies were found relevant and were included in this systematic review. The review found that most studies had a moderate risk of bias based on the Newcastle-Ottawa Scale, with only three rated as low risk. Key factors linked to poor glycemic control included low socioeconomic status, medication non-adherence, longer diabetes duration, obesity, insulin-based regimens, and limited access to healthcare. Insulin use, in particular, was paradoxically associated with worse control due to its complexity and adherence challenges, especially in low-resource settings. Regional differences highlighted unique barriers like cultural practices in Ethiopia and gaps in diabetes education in Eritrea. These findings reflect the complex and context-specific nature of glycemic control, especially in low- and middle-income countries. The review calls for simplified treatments, affordable medications, and better management of comorbidities, while encouraging future research using longitudinal and mixed-methods approaches to guide more effective, patient-centered interventions.

Indexed as

diabete type 2glycemic controlhba1csystematic reviewt2dm

Identifiers

PMID40385776
PMCPMC12085201

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.